Lista de obras - Christina Curtis - Dominio Público Uruguay

A Big Bang model of human colorectal tumor growth

artículo científico publicado en 2015

A population genetics perspective on the determinants of intra-tumor heterogeneity

artículo científico publicado en 2017

A role for chromatin regulatory dynamics in breast cancer evolution

artículo científico publicado en 2018

A screen of apoptosis and senescence regulatory genes for life span effects when over-expressed in Drosophila

artículo científico publicado en 2009

A sparse regulatory network of copy-number driven expression reveals putative breast cancer oncogenes

A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer

artículo científico publicado en 2014

AGBT meeting report.

artículo científico publicado en 2018

Abstract 5016: The human sub-ependymal zone harbors glioblastoma precursors and represents a distinct therapeutic target

Abstract SY36-01: Exploiting intra-tumor heterogeneity through agent-based models of tumor growth to infer properties of human malignancies

Author Correction: Quantification of subclonal selection in cancer from bulk sequencing data

scientific article published on 01 September 2018

Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in Cancer Cells

artículo científico publicado en 2017

Big Bang Tumor Growth and Clonal Evolution

artículo científico publicado en 2017

CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities

artículo científico publicado en 2020

Calling sample mix-ups in cancer population studies

artículo científico publicado en 2012

Characterizing the ecological and evolutionary dynamics of cancer

artículo científico publicado en 2020

Chromatin regulators mediate anthracycline sensitivity in breast cancer

artículo científico publicado en 2019

Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy

artículo científico publicado en 2019

Clonal replacement of tumor-specific T cells following PD-1 blockade

artículo científico publicado en 2019

Contributions to drug resistance in glioblastoma derived from malignant cells in the sub-ependymal zone

artículo científico publicado en 2015

Drosophila melanogaster p53 has developmental stage-specific and sex-specific effects on adult life span indicative of sexual antagonistic pleiotropy

artículo científico publicado en 2009

Early mutation bursts in colorectal tumors

artículo científico publicado en 2017

Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers

artículo científico publicado en 2012

Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer

artículo científico publicado en 2017

Erratum to: Transcriptional profiling of MnSOD-mediated lifespan extension in Drosophila reveals a species-general network of aging and metabolic genes

artículo científico publicado en 2016

Explaining differences in saturation levels for Affymetrix GeneChip arrays

artículo científico publicado en 2007

Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer

artículo científico publicado en 2016

Genome-driven integrated classification of breast cancer validated in over 7,500 samples

artículo científico publicado en 2014

Genomic profiling of breast cancers

artículo científico publicado en 2015

Improving breast cancer survival analysis through competition-based multidimensional modeling

artículo científico publicado en 2013

Inferring Tumor Phylogenies from Multi-region Sequencing

artículo científico publicado en 2016

Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics.

artículo científico publicado en 2013

Looking backward in time to define the chronology of metastasis

artículo científico publicado en 2020

Many private mutations originate from the first few divisions of a human colorectal adenoma.

artículo científico publicado en 2015

Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice.

artículo científico publicado en 2018

Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases

scientific article published on 18 May 2020

Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)

artículo científico publicado en 2020

Penalized regression elucidates aberration hotspots mediating subtype-specific transcriptional responses in breast cancer

artículo científico publicado en 2011

Precise inference of copy number alterations in tumor samples from SNP arrays

artículo científico publicado en 2013

Product length, dye choice, and detection chemistry in the bead-emulsion amplification of millions of single DNA molecules in parallel

artículo científico publicado en 2009

Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy.

artículo científico publicado en 2019

Quantification of subclonal selection in cancer from bulk sequencing data

artículo científico publicado en 2018

Quantitative evidence for early metastatic seeding in colorectal cancer

artículo científico publicado en 2019

Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling

artículo científico publicado en 2012

Single-molecule genomic data delineate patient-specific tumor profiles and cancer stem cell organization

artículo científico publicado en 2012

Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response

artículo científico publicado en 2021

Swift: primary data analysis for the Illumina Solexa sequencing platform.

artículo científico publicado en 2009

Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancer

artículo científico publicado en 2013

The Breast Cancer Oncogene EMSY Represses Transcription of Antimetastatic microRNA miR-31.

artículo científico publicado en 2014

The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31.

artículo científico publicado en 2014

The clonal and mutational evolution spectrum of primary triple-negative breast cancers

artículo científico publicado en 2012

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

artículo científico publicado en 2012

The importance of platform annotation in interpreting microarray data

article by Mark J. Dunning et al published August 2010 in Lancet Oncology Commission

The m6A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor

artículo científico publicado en 2020

The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer

artículo científico publicado en 2021

The pitfalls of platform comparison: DNA copy number array technologies assessed

artículo científico publicado en 2009

The shaping and functional consequences of the microRNA landscape in breast cancer

artículo científico publicado en 2013

Transcriptional profiling of MnSOD-mediated lifespan extension in Drosophila reveals a species-general network of aging and metabolic genes

artículo científico publicado en 2007

ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium

artículo científico publicado en 2011

Lista de obras de Christina Curtis

A Big Bang model of human colorectal tumor growth

A population genetics perspective on the determinants of intra-tumor heterogeneity

A role for chromatin regulatory dynamics in breast cancer evolution

A screen of apoptosis and senescence regulatory genes for life span effects when over-expressed in Drosophila

A sparse regulatory network of copy-number driven expression reveals putative breast cancer oncogenes

A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer

AGBT meeting report.

Abstract 5016: The human sub-ependymal zone harbors glioblastoma precursors and represents a distinct therapeutic target

Abstract SY36-01: Exploiting intra-tumor heterogeneity through agent-based models of tumor growth to infer properties of human malignancies

Author Correction: Quantification of subclonal selection in cancer from bulk sequencing data

Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in Cancer Cells

Big Bang Tumor Growth and Clonal Evolution

CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities

Calling sample mix-ups in cancer population studies

Characterizing the ecological and evolutionary dynamics of cancer

Chromatin regulators mediate anthracycline sensitivity in breast cancer

Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy

Clonal replacement of tumor-specific T cells following PD-1 blockade

Contributions to drug resistance in glioblastoma derived from malignant cells in the sub-ependymal zone

Drosophila melanogaster p53 has developmental stage-specific and sex-specific effects on adult life span indicative of sexual antagonistic pleiotropy

Early mutation bursts in colorectal tumors

Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers

Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer

Erratum to: Transcriptional profiling of MnSOD-mediated lifespan extension in Drosophila reveals a species-general network of aging and metabolic genes

Explaining differences in saturation levels for Affymetrix GeneChip arrays

Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer

Genome-driven integrated classification of breast cancer validated in over 7,500 samples

Genomic profiling of breast cancers

Improving breast cancer survival analysis through competition-based multidimensional modeling

Inferring Tumor Phylogenies from Multi-region Sequencing

Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics.

Looking backward in time to define the chronology of metastasis

Many private mutations originate from the first few divisions of a human colorectal adenoma.

Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice.

Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases

Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)

Penalized regression elucidates aberration hotspots mediating subtype-specific transcriptional responses in breast cancer

Precise inference of copy number alterations in tumor samples from SNP arrays

Product length, dye choice, and detection chemistry in the bead-emulsion amplification of millions of single DNA molecules in parallel

Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy.

Quantification of subclonal selection in cancer from bulk sequencing data

Quantitative evidence for early metastatic seeding in colorectal cancer

Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling

Single-molecule genomic data delineate patient-specific tumor profiles and cancer stem cell organization

Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response

Swift: primary data analysis for the Illumina Solexa sequencing platform.

Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancer

The Breast Cancer Oncogene EMSY Represses Transcription of Antimetastatic microRNA miR-31.

The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31.

The clonal and mutational evolution spectrum of primary triple-negative breast cancers

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

The importance of platform annotation in interpreting microarray data

The m6A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor

The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer

The pitfalls of platform comparison: DNA copy number array technologies assessed

The shaping and functional consequences of the microRNA landscape in breast cancer

Transcriptional profiling of MnSOD-mediated lifespan extension in Drosophila reveals a species-general network of aging and metabolic genes

ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium